T lymphocyte activation through the C28 pathway is insensitive to inhibition by the immunosuppressive drug FK-506

This publication has 21 references indexed in Scilit:

• The CD2 antigen associates with the T-cell antigen receptor CD3 antigen complex on the surface of human T lymphocytes
  Nature, 1989
• EFFECT OF A NEW IMMUNOSUPPRESSIVE AGENT, FK506, ON HUMAN LYMPHOCYTE RESPONSES IN VITRO
  Transplantation, 1989
• FK-506 — How much potential?
  Immunology Today, 1989
• Immunosuppressive effect of FK506 on experimental allergic encephalomyelitis in rats
  International Journal of Immunopharmacology, 1988
• STUDIES OF THE INDUCTION AND MAINTENANCE OF LONG-TERM GRAFT ACCEPTANCE BY TREATMENT WITH FK506 IN HETEROTOPIC CARDIAC ALLOTRANSPLANTATION IN RATS
  Transplantation, 1987
• T‐Lymphocyte Activation: The Role of Protein Kinase C and the Bifurcating Inositol Phospholipid Signal Transduction Pathway
  Immunological Reviews, 1987
• FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.
  The Journal of Antibiotics, 1987
• Transmembrane signalling via the T11‐dependent pathway of human T cell activation. Evidence for the involvement of 1,2‐diacylglycerol and inositol phosphates
  European Journal of Immunology, 1987
• Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen).
  The Journal of Experimental Medicine, 1985
• An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein
  Cell, 1984